Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for SeaStar Medical Holding (ICUCW) over the last 3 years, with Q3 2025 value amounting to $26.4 million.

  • SeaStar Medical Holding's Shares Outstanding (Weighted Average) rose 54580.95% to $26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.4 million, marking a year-over-year increase of 54580.95%. This contributed to the annual value of $3.7 million for FY2024, which is 33187.56% up from last year.
  • According to the latest figures from Q3 2025, SeaStar Medical Holding's Shares Outstanding (Weighted Average) is $26.4 million, which was up 54580.95% from $11.3 million recorded in Q2 2025.
  • Over the past 5 years, SeaStar Medical Holding's Shares Outstanding (Weighted Average) peaked at $26.4 million during Q3 2025, and registered a low of $597315.0 during Q2 2023.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $6.8 million, with a median of $3.7 million in 2024.
  • Per our database at Business Quant, SeaStar Medical Holding's Shares Outstanding (Weighted Average) tumbled by 7939.3% in 2024 and then surged by 54580.95% in 2025.
  • SeaStar Medical Holding's Shares Outstanding (Weighted Average) (Quarter) stood at $866813.0 in 2023, then surged by 331.88% to $3.7 million in 2024, then soared by 605.04% to $26.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $26.4 million in Q3 2025, compared to $11.3 million in Q2 2025 and $8.6 million in Q1 2025.